{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T01:56:25Z","timestamp":1794534985750,"version":"4.9.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,10,19]],"date-time":"2017-10-19T00:00:00Z","timestamp":1508371200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,10,19]],"date-time":"2017-10-19T00:00:00Z","timestamp":1508371200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstact<\/jats:title><jats:p>The gut hormone glucagon-like peptide (GLP)-1 and its analogues represent a new generation of anti-diabetic drugs, which have also demonstrated propensity to modulate host lipid metabolism. Despite this, drugs of this nature are currently limited to intramuscular administration routes due to intestinal degradation. The aim of this study was to design a recombinant microbial delivery vector for a GLP-1 analogue and assess the efficacy of the therapeutic in improving host glucose, lipid and cholesterol metabolism in diet induced obese rodents. Diet-induced obese animals received either Lactobacillus paracasei NFBC 338 transformed to express a long-acting analogue of GLP-1 or the isogenic control microbe which solely harbored the pNZ44 plasmid. Short-term GLP-1 microbe intervention in rats reduced serum low-density lipoprotein cholesterol, triglycerides and triglyceride-rich lipoprotein cholesterol substantially. Conversely, extended GLP-1 microbe intervention improved glucose-dependent insulin secretion, glucose metabolism and cholesterol metabolism, compared to the high-fat control group. Interestingly, the microbe significantly attenuated the adiposity associated with the model and altered the serum lipidome, independently of GLP-1 secretion. These data indicate that recombinant incretin-secreting microbes may offer a novel and safe means of managing cholesterol metabolism and diet induced dyslipidaemia, as well as insulin sensitivity in metabolic dysfunction.<\/jats:p>","DOI":"10.1038\/s41598-017-14010-x","type":"journal-article","created":{"date-parts":[[2017,10,13]],"date-time":"2017-10-13T09:13:37Z","timestamp":1507886017000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Recombinant Incretin-Secreting Microbe Improves Metabolic Dysfunction in High-Fat Diet Fed Rodents"],"prefix":"10.1038","volume":"7","author":[{"given":"Paul M.","family":"Ryan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine","family":"Patterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert M.","family":"Kent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena","family":"Stack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula M.","family":"O\u2019Connor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiera","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica L.","family":"Peterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rupasri","family":"Mandal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David S.","family":"Wishart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy G.","family":"Dinan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5887-2723","authenticated-orcid":false,"given":"John F.","family":"Cryan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randy J.","family":"Seeley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Stanton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. Paul","family":"Ross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,10,19]]},"reference":[{"key":"14010_CR1","doi-asserted-by":"publisher","first-page":"3406","DOI":"10.1172\/jci27207","volume":"115","author":"DA D\u2019Alessio","year":"2005","unstructured":"D\u2019Alessio, D. A., Sandoval, D. A. & Seeley, R. J. New ways in which GLP-1 can regulate glucose homeostasis. The Journal of clinical investigation 115, 3406\u20133408, https:\/\/doi.org\/10.1172\/jci27207 (2005).","journal-title":"The Journal of clinical investigation"},{"key":"14010_CR2","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.2337\/db07-1788","volume":"57","author":"C Knauf","year":"2008","unstructured":"Knauf, C. et al. Role of central nervous system glucagon-like peptide-1 receptors in enteric glucose sensing. Diabetes 57, 2603\u20132612 doi:10.2337\/db07-1788 (2008).","journal-title":"Diabetes"},{"key":"14010_CR3","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1161\/atvbaha.114.304873","volume":"35","author":"S Farr","year":"2015","unstructured":"Farr, S. et al. Central Nervous System Regulation of Intestinal Lipoprotein Metabolism by Glucagon-Like Peptide-1 via a Brain\u2013Gut Axis. Arteriosclerosis, Thrombosis, and Vascular Biology 35, 1092\u20131100, https:\/\/doi.org\/10.1161\/atvbaha.114.304873 (2015).","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"key":"14010_CR4","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1111\/j.1478-3231.2011.02462.x","volume":"31","author":"G Svegliati-Baroni","year":"2011","unstructured":"Svegliati-Baroni, G. et al. Glucagon-like peptide-1 receptor activation stimulates hepatic lipid oxidation and restores hepatic signalling alteration induced by a high-fat diet in nonalcoholic steatohepatitis. Liver international: official journal of the International Association for the Study of the Liver 31, 1285\u20131297, https:\/\/doi.org\/10.1111\/j.1478-3231.2011.02462.x (2011).","journal-title":"Liver international: official journal of the International Association for the Study of the Liver"},{"key":"14010_CR5","doi-asserted-by":"publisher","first-page":"R910","DOI":"10.1152\/ajpregu.1999.277.3.R910","volume":"277","author":"E N\u00e4slund","year":"1999","unstructured":"N\u00e4slund, E. et al. GLP-1 slows solid gastric emptying and inhibits insulin, glucagon, and PYY release in humans. American Journal of Physiology - Regulatory, Integrative and Comparative Physiology 277, R910\u2013R916 (1999).","journal-title":"American Journal of Physiology - Regulatory, Integrative and Comparative Physiology"},{"key":"14010_CR6","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1016\/j.atherosclerosis.2013.12.047","volume":"233","author":"C Xiao","year":"2014","unstructured":"Xiao, C., Dash, S., Morgantini, C. & Lewis, G. F. New and emerging regulators of intestinal lipoprotein secretion. Atherosclerosis 233, 608\u2013615, https:\/\/doi.org\/10.1016\/j.atherosclerosis.2013.12.047 (2014).","journal-title":"Atherosclerosis"},{"key":"14010_CR7","doi-asserted-by":"publisher","unstructured":"Voukali, M. et al. Study of Postprandial Lipaemia in Type 2 Diabetes Mellitus: Exenatide versus Liraglutide. Journal of Diabetes Research 2014, 7, http:\/\/dx.doi.org\/10.1155\/2014\/304032 (2014).","DOI":"10.1155\/2014\/304032"},{"key":"14010_CR8","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.atherosclerosis.2010.05.028","volume":"212","author":"EA Schwartz","year":"2010","unstructured":"Schwartz, E. A. et al. Exenatide suppresses postprandial elevations in lipids and lipoproteins in individuals with impaired glucose tolerance and recent onset type 2 diabetes mellitus. Atherosclerosis 212, 217\u2013222 (2010).","journal-title":"Atherosclerosis"},{"key":"14010_CR9","doi-asserted-by":"publisher","unstructured":"Hermansen, K. et al. Liraglutide suppresses postprandial triglyceride and apolipoprotein B48 elevations after a fat\u2010rich meal in patients with type 2 diabetes: a randomized, double\u2010blind, placebo\u2010controlled, cross\u2010over trial. Diabetes, Obesity and Metabolism 15, 1040\u20131048, doi:10.1111\/dom.12133 (2013).","DOI":"10.1111\/dom.12133"},{"key":"14010_CR10","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.atherosclerosissup.2008.05.004","volume":"9","author":"DF Vine","year":"2008","unstructured":"Vine, D. F., Glimm, D. R. & Proctor, S. D. Intestinal lipid transport and chylomicron production: possible links to exacerbated atherogenesis in a rodent model of the metabolic syndrome. Atherosclerosis. Supplements 9, 69\u201376, https:\/\/doi.org\/10.1016\/j.atherosclerosissup.2008.05.004 (2008).","journal-title":"Atherosclerosis. Supplements"},{"key":"14010_CR11","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-015-0188-1","volume":"14","author":"K Torimoto","year":"2015","unstructured":"Torimoto, K. et al. Effects of exenatide on postprandial vascular endothelial dysfunction in type 2 diabetes mellitus. Cardiovascular diabetology 14, 25, doi:10.1186\/s12933-015-0188-1 (2015).","journal-title":"Cardiovascular diabetology"},{"issue":"5","key":"14010_CR12","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1038\/nm.3128","volume":"19","author":"Minsuk Kim","year":"2013","unstructured":"Kim, M. et al. GLP-1 receptor activation and Epac2 link atrial natriuretic peptide secretion to control of blood pressure. Nat Med 19, 567\u2013575, https:\/\/doi.org\/10.1038\/nm.3128 (2013).","journal-title":"Nature Medicine"},{"key":"14010_CR13","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1097\/mco.0000000000000224","volume":"18","author":"PM Ryan","year":"2015","unstructured":"Ryan, P. M., Ross, R. P., Fitzgerald, G. F., Caplice, N. M. & Stanton, C. Functional food addressing heart health: do we have to target the gut microbiota? Current opinion in clinical nutrition and metabolic care 18, 566\u2013571, https:\/\/doi.org\/10.1097\/mco.0000000000000224 (2015).","journal-title":"Current opinion in clinical nutrition and metabolic care"},{"key":"14010_CR14","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.gene.2013.11.081","volume":"537","author":"M Remely","year":"2014","unstructured":"Remely, M. et al. Effects of short chain fatty acid producing bacteria on epigenetic regulation of FFAR3 in type 2 diabetes and obesity. Gene 537, 85\u201392, https:\/\/doi.org\/10.1016\/j.gene.2013.11.081 (2014).","journal-title":"Gene"},{"key":"14010_CR15","doi-asserted-by":"publisher","first-page":"3391","DOI":"10.1172\/JCI72517","volume":"124","author":"Z Chen","year":"2014","unstructured":"Chen, Z. et al. Incorporation of therapeutically modified bacteria into gut microbiota inhibits obesity. The Journal of clinical investigation 124, 3391\u20133406, https:\/\/doi.org\/10.1172\/JCI72517 (2014).","journal-title":"The Journal of clinical investigation"},{"key":"14010_CR16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0109461","volume":"9","author":"C Ai","year":"2014","unstructured":"Ai, C. et al. Genetically Engineered Lactococcus lactis Protect against House Dust Mite Allergy in a BALB\/c Mouse Model. PLoS One 9, e109461, https:\/\/doi.org\/10.1371\/journal.pone.0109461 (2014).","journal-title":"PLoS One"},{"key":"14010_CR17","doi-asserted-by":"publisher","first-page":"7421","DOI":"10.1073\/pnas.1323599111","volume":"111","author":"SA Joyce","year":"2014","unstructured":"Joyce, S. A. et al. Regulation of host weight gain and lipid metabolism by bacterial bile acid modification in the gut. Proceedings of the National Academy of Sciences 111, 7421\u20137426, https:\/\/doi.org\/10.1073\/pnas.1323599111 (2014).","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"14010_CR18","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/nrmicro1840","volume":"6","author":"JM Wells","year":"2008","unstructured":"Wells, J. M. & Mercenier, A. Mucosal delivery of therapeutic and prophylactic molecules using lactic acid bacteria. Nature reviews. Microbiology 6, 349\u2013362, https:\/\/doi.org\/10.1038\/nrmicro1840 (2008).","journal-title":"Nature reviews. Microbiology"},{"key":"14010_CR19","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1016\/j.copbio.2012.01.001","volume":"23","author":"TC Aurand","year":"2012","unstructured":"Aurand, T. C., Russell, M. S. & March, J. C. Synthetic signaling networks for therapeutic applications. Curr Opin Biotechnol 23, 773\u2013779, https:\/\/doi.org\/10.1016\/j.copbio.2012.01.001 (2012).","journal-title":"Curr Opin Biotechnol"},{"issue":"5","key":"14010_CR20","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.2337\/db14-0635","volume":"64","author":"Franklin F. Duan","year":"2015","unstructured":"Duan, F. F., Liu, J. H. & March, J. C. Engineered Commensal Bacteria Reprogram Intestinal Cells Into Glucose-Responsive Insulin-Secreting Cells for the Treatment of Diabetes. Diabetes, 64, 1794\u2013803, https:\/\/doi.org\/10.2337\/db14-0635 (2015).","journal-title":"Diabetes"},{"key":"14010_CR21","doi-asserted-by":"publisher","unstructured":"Arora, T. et al. Microbially produced glucagon-like peptide 1 improves glucose tolerance in mice. Molecular Metabolism 22, 725\u201330, doi:10.1016\/j.molmet.2016.06.006 (2016).","DOI":"10.1016\/j.molmet.2016.06.006"},{"key":"14010_CR22","doi-asserted-by":"publisher","unstructured":"Holst, J. J. The physiology of glucagon-like peptide 1. Physiological reviews 87, 1409\u20131439, doi:10.1152\/physrev.00034.2006 (2007).","DOI":"10.1152\/physrev.00034.2006"},{"key":"14010_CR23","unstructured":"International Diabetes Federation. IDF Diabetes Atlas update poster. International Diabetes Federation (2014)."},{"key":"14010_CR24","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1055\/s-2004-826160","volume":"36","author":"CF Deacon","year":"2003","unstructured":"Deacon, C. F. Circulation and degradation of GIP and GLP-1. Hormone and metabolic research 36, 761\u2013765, doi:10.1055\/s-2004-826160 (2003).","journal-title":"Hormone and metabolic research=Hormon-und Stoffwechselforschung=Hormones et metabolisme"},{"key":"14010_CR25","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1126\/science.289.5483.1352","volume":"289","author":"L Steidler","year":"2000","unstructured":"Steidler, L. et al. Treatment of murine colitis by Lactococcus lactis secreting interleukin-10. Science (New York, N.Y.) 289, 1352\u20131355, doi:10.1126\/science.289.5483.1352 (2000).","journal-title":"Science (New York, N.Y.)"},{"key":"14010_CR26","doi-asserted-by":"publisher","first-page":"993","DOI":"10.4158\/ep.14.8.993","volume":"14","author":"R Bhushan","year":"2008","unstructured":"Bhushan, R. et al. Exenatide use in the management of metabolic syndrome: a retrospective database study. Endocrine practice: official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 14, 993\u2013999, https:\/\/doi.org\/10.4158\/ep.14.8.993 (2008).","journal-title":"Endocrine practice: official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists"},{"key":"14010_CR27","doi-asserted-by":"publisher","first-page":"2394","DOI":"10.2337\/db13-1654","volume":"63","author":"C Xiao","year":"2014","unstructured":"Xiao, C., Dash, S., Morgantini, C., Patterson, B. W. & Lewis, G. F. Sitagliptin, a DPP-4 inhibitor, acutely inhibits intestinal lipoprotein particle secretion in healthy humans. Diabetes 63, 2394\u20132401, https:\/\/doi.org\/10.2337\/db13-1654 (2014).","journal-title":"Diabetes"},{"key":"14010_CR28","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1161\/atvbaha.112.246207","volume":"32","author":"C Xiao","year":"2012","unstructured":"Xiao, C., Bandsma, R. H., Dash, S., Szeto, L. & Lewis, G. F. Exenatide, a glucagon-like peptide-1 receptor agonist, acutely inhibits intestinal lipoprotein production in healthy humans. Arterioscler Thromb Vasc Biol 32, 1513\u20131519, https:\/\/doi.org\/10.1161\/atvbaha.112.246207 (2012).","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"14010_CR29","doi-asserted-by":"publisher","first-page":"158","DOI":"10.2337\/dc15-0750","volume":"39","author":"Sarah Steven","year":"2015","unstructured":"Steven, S. et al. Weight Loss Decreases Excess Pancreatic Triacylglycerol Specifically in Type 2 Diabetes. Diabetes Care, https:\/\/doi.org\/10.2337\/dc15-0750 (2015).","journal-title":"Diabetes Care"},{"key":"14010_CR30","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1097\/mco.0000000000000025","volume":"17","author":"E Puertollano","year":"2014","unstructured":"Puertollano, E., Kolida, S. & Yaqoob, P. Biological significance of short-chain fatty acid metabolism by the intestinal microbiome. Current opinion in clinical nutrition and metabolic care 17, 139\u2013144, https:\/\/doi.org\/10.1097\/mco.0000000000000025 (2014).","journal-title":"Current opinion in clinical nutrition and metabolic care"},{"key":"14010_CR31","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1111\/j.1758-2229.2009.00116.x","volume":"2","author":"A Mihajlovski","year":"2010","unstructured":"Mihajlovski, A., Dor\u00e9, J., Levenez, F., Alric, M. & Brug\u00e8re, J.-F. Molecular evaluation of the human gut methanogenic archaeal microbiota reveals an age-associated increase of the diversity. Environmental Microbiology Reports 2, 272\u2013280, https:\/\/doi.org\/10.1111\/j.1758-2229.2009.00116.x (2010).","journal-title":"Environmental Microbiology Reports"},{"key":"14010_CR32","doi-asserted-by":"publisher","first-page":"639","DOI":"10.2337\/db12-0495","volume":"62","author":"A Floegel","year":"2013","unstructured":"Floegel, A. et al. Identification of serum metabolites associated with risk of type 2 diabetes using a targeted metabolomic approach. Diabetes 62, 639\u2013648, https:\/\/doi.org\/10.2337\/db12-0495 (2013).","journal-title":"Diabetes"},{"key":"14010_CR33","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1194\/jlr.M002774","volume":"51","author":"VR Velagapudi","year":"2010","unstructured":"Velagapudi, V. R. et al. The gut microbiota modulates host energy and lipid metabolism in mice. Journal of Lipid Research 51, 1101\u20131112, https:\/\/doi.org\/10.1194\/jlr.M002774 (2010).","journal-title":"Journal of Lipid Research"},{"key":"14010_CR34","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1016\/j.cmet.2015.07.026","volume":"22","author":"R Caesar","year":"2015","unstructured":"Caesar, R., Tremaroli, V., Kovatcheva-Datchary, P., Cani, Patrice, D. & B\u00e4ckhed, F. Crosstalk between Gut Microbiota and Dietary Lipids Aggravates WAT Inflammation through TLR Signaling. Cell Metabolism 22, 658\u2013668, https:\/\/doi.org\/10.1016\/j.cmet.2015.07.026 (2015).","journal-title":"Cell Metabolism"},{"key":"14010_CR35","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1128\/AEM.64.3.818-823.1998","volume":"64","author":"N Horn","year":"1998","unstructured":"Horn, N. et al. Production of pediocin PA-1 by Lactococcus lactis using the lactococcin A secretory apparatus. Applied and environmental microbiology 64, 818\u2013823 (1998).","journal-title":"Applied and environmental microbiology"},{"key":"14010_CR36","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1128\/aem.67.2.608-616.2001","volume":"67","author":"S McGrath","year":"2001","unstructured":"McGrath, S., Fitzgerald, G. F. & van Sinderen, D. Improvement and Optimization of Two Engineered Phage Resistance Mechanisms in Lactococcus lactis. Applied and Environmental Microbiology 67, 608\u2013616, https:\/\/doi.org\/10.1128\/aem.67.2.608-616.2001 (2001).","journal-title":"Applied and Environmental Microbiology"},{"key":"14010_CR37","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1128\/AEM.01524-09","volume":"76","author":"HM Stack","year":"2010","unstructured":"Stack, H. M., Kearney, N., Stanton, C., Fitzgerald, G. F. & Ross, R. P. Association of beta-glucan endogenous production with increased stress tolerance of intestinal lactobacilli. Appl Environ Microbiol 76, 500\u2013507, https:\/\/doi.org\/10.1128\/AEM.01524-09 (2010).","journal-title":"Appl Environ Microbiol"},{"issue":"3","key":"14010_CR38","doi-asserted-by":"publisher","first-page":"e52611","DOI":"10.1371\/journal.pone.0052611","volume":"8","author":"Manuela Salvucci","year":"2013","unstructured":"Salvucci, M., Neufeld, Z. & Newsholme, P. Mathematical Model of Metabolism and Electrophysiology of Amino Acid and Glucose Stimulated Insulin Secretion: In Vitro Validation Using a \u03b2-Cell Line. Plos One 8, e52611, https:\/\/doi.org\/10.1371\/journal.pone.0052611 (2013).","journal-title":"PLoS ONE"},{"key":"14010_CR39","doi-asserted-by":"publisher","unstructured":"Geurts, L. et al. Adipose tissue NAPE-PLD controls fat mass development by altering the browning process and gut microbiota. Nature communications 6, doi:10.1038\/ncomms7495 (2015).","DOI":"10.1038\/ncomms7495"},{"issue":"1","key":"14010_CR40","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1475-2840-13-5","volume":"13","author":"Dolores Corella","year":"2014","unstructured":"Hermans, M. P., Ahn, S. A. & Rousseau, M. F. Novel unbiased equations to calculate triglyceride-rich lipoprotein cholesterol from routine non-fasting lipids. Cardiovascular diabetology 13, 1\u20138, doi:10.1186\/1475-2840-13-56 (2014).","journal-title":"Cardiovascular Diabetology"},{"key":"14010_CR41","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2840-9-88","volume":"9","author":"MP Hermans","year":"2010","unstructured":"Hermans, M. P., Ahn, S. A. & Rousseau, M. F. log (TG)\/HDL-C is related to both residual cardiometabolic risk and b-cell function loss in type 2 diabetes males. Cardiovasc Diabetol 9, 88, doi:10.1186\/1475-2840-9-88 (2010).","journal-title":"Cardiovasc Diabetol"},{"key":"14010_CR42","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1128\/AEM.01903-09","volume":"76","author":"SD Hamilton-Brehm","year":"2010","unstructured":"Hamilton-Brehm, S. D. et al. Caldicellulosiruptor obsidiansis sp. nov., an anaerobic, extremely thermophilic, cellulolytic bacterium isolated from Obsidian Pool, Yellowstone National Park. Applied and Environmental Microbiology 76, 1014\u20131020, https:\/\/doi.org\/10.1128\/AEM.01903-09 (2010).","journal-title":"Applied and Environmental Microbiology"},{"key":"14010_CR43","doi-asserted-by":"publisher","unstructured":"Xia, J. & Wishart, D. S. Metabolomic data processing, analysis, and interpretation using MetaboAnalyst. Current Protocols in Bioinformatics 14, doi:10.1002\/0471250953.bi1410s34 (2002).","DOI":"10.1002\/0471250953.bi1410s34"},{"key":"14010_CR44","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-12-253","volume":"12","author":"K-A L\u00ea Cao","year":"2011","unstructured":"L\u00ea Cao, K.-A., Boitard, S. & Besse, P. Sparse PLS discriminant analysis: biologically relevant feature selection and graphical displays for multiclass problems. BMC bioinformatics 12, 253, https:\/\/doi.org\/10.1186\/1471-2105-12-253 (2011).","journal-title":"BMC bioinformatics"}],"updated-by":[{"DOI":"10.1038\/s41598-020-59133-w","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2020,2,6]],"date-time":"2020-02-06T00:00:00Z","timestamp":1580947200000}}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-14010-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-14010-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-14010-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T12:10:12Z","timestamp":1671797412000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-14010-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,19]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12]]}},"alternative-id":["14010"],"URL":"https:\/\/doi.org\/10.1038\/s41598-017-14010-x","relation":{"correction":[{"id-type":"doi","id":"10.1038\/s41598-020-59133-w","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,19]]},"assertion":[{"value":"13 July 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 October 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2020","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"An amendment to this paper has been published and can be accessed via a link at the top of the paper.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"RJS receives compensation for consultancy work as a member of scientific advisory board or research support from Ethicon Endo-Surgery, Novo Nordisk, Novartis, Paul Hastings Law Firm, Zafgen, MedImmune and Sanofi. All other authors declare no duality of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"13523"}}